{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:58:18Z","timestamp":1787237898116,"version":"build-2736575974"},"reference-count":87,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Koch Institute Frontier Research Program","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100006507","name":"Deshpande Center","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100006507","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ludwig graduate fellowship","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM144273"],"award-info":[{"award-number":["T32GM144273"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023581","name":"National Science Foundation Graduate Research Fellowship Program","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100023581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA14051"],"award-info":[{"award-number":["P30-CA14051"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"A*STAR","doi-asserted-by":"crossref","award":["C210112058"],"award-info":[{"award-number":["C210112058"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001348","name":"A*STAR","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000008","name":"David and Lucile Packard Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006754","name":"Army Research Laboratory","doi-asserted-by":"publisher","award":["W911NF-19-2-0026"],"award-info":[{"award-number":["W911NF-19-2-0026"]}],"id":[{"id":"10.13039\/100006754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000875","name":"Pew Charitable Trusts","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,1,20]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chimeric antigen receptor (CAR) therapies have demonstrated potent efficacy in treating B-cell malignancies, but have yet to meaningfully translate to solid tumors. Nonetheless, they are of particular interest for the treatment of glioblastoma, which is an aggressive form of brain cancer with few effective therapeutic options, due to their ability to cross the highly selective blood-brain barrier.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Here, we use our pooled screening platform, CARPOOL, to expedite the discovery of CARs with antitumor functions necessary for solid tumor efficacy. We performed selections in primary human T cells expressing a library of 1.3\u00d710\n                      <jats:sup>6<\/jats:sup>\n                      third generation CARs targeting IL-13R\u03b12, a cancer testis antigen commonly expressed in glioblastoma. Selections were performed for cytotoxicity, proliferation, memory formation, and persistence on repeated antigen challenge.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Each enriched CAR robustly produced the phenotype for which it was selected, and one enriched CAR triggered potent cytotoxicity and long-term proliferation on in vitro tumor rechallenge. It also showed significantly improved persistence and comparable tumor control in a microphysiological human in vitro model and a xenograft model of human glioblastoma, but also demonstrated increased off-target recognition of IL-13R\u03b11.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Taken together, this work demonstrates the utility of extending CARPOOL to diseases beyond hematological malignancies and represents the largest exploration of signaling combinations in human primary cells to date.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2024-009574","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T12:50:32Z","timestamp":1739278232000},"page":"e009574","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Pooled screening for CAR function identifies novel IL-13R\u03b12-targeted CARs for treatment of glioblastoma"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3652-7245","authenticated-orcid":false,"given":"Khloe S","family":"Gordon","sequence":"first","affiliation":[{"name":"Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Singapore-MIT Alliance for Research and Technology Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb R","family":"Perez","sequence":"additional","affiliation":[{"name":"Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Singapore-MIT Alliance for Research and Technology Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Garmilla","sequence":"additional","affiliation":[{"name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Program in Immunology, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine S Y","family":"Lam","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey J Y","family":"Aw","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Datta","sequence":"additional","affiliation":[{"name":"Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A","family":"Lauffenburger","sequence":"additional","affiliation":[{"name":"Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pavesi","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Cell Biology, Agency for Science Technology and Research (A*STAR), Singapore"},{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2281-3518","authenticated-orcid":false,"given":"Michael E","family":"Birnbaum","sequence":"additional","affiliation":[{"name":"Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Singapore-MIT Alliance for Research and Technology Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"2025100303463027000_13.2.e009574.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0003-5"},{"key":"2025100303463027000_13.2.e009574.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1824"},{"key":"2025100303463027000_13.2.e009574.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00139-y"},{"key":"2025100303463027000_13.2.e009574.4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat Rev Mater"},{"key":"2025100303463027000_13.2.e009574.5","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070064"},{"key":"2025100303463027000_13.2.e009574.6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.5.2187"},{"key":"2025100303463027000_13.2.e009574.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0010-1"},{"key":"2025100303463027000_13.2.e009574.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-683847"},{"key":"2025100303463027000_13.2.e009574.9","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2446"},{"key":"2025100303463027000_13.2.e009574.10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature New Biol"},{"key":"2025100303463027000_13.2.e009574.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610497"},{"key":"2025100303463027000_13.2.e009574.12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0709"},{"key":"2025100303463027000_13.2.e009574.13","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4086"},{"key":"2025100303463027000_13.2.e009574.14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41590-020-0676-7","article-title":"Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity","volume":"21","author":"Lai","year":"2020","journal-title":"Nat Immunol"},{"key":"2025100303463027000_13.2.e009574.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0192-1"},{"key":"2025100303463027000_13.2.e009574.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.05.011"},{"key":"2025100303463027000_13.2.e009574.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0564-6"},{"key":"2025100303463027000_13.2.e009574.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"2025100303463027000_13.2.e009574.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116133"},{"key":"2025100303463027000_13.2.e009574.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"2025100303463027000_13.2.e009574.21","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.24"},{"key":"2025100303463027000_13.2.e009574.22","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.662064","article-title":"CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma","volume":"15","author":"Maggs","year":"2021","journal-title":"Front Neurosci"},{"key":"2025100303463027000_13.2.e009574.23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4963","article-title":"Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma","volume":"7","author":"Johnson","year":"2015","journal-title":"Sci Transl Med"},{"key":"2025100303463027000_13.2.e009574.24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.669071","article-title":"Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma","volume":"11","author":"Durgin","year":"2021","journal-title":"Front Oncol"},{"key":"2025100303463027000_13.2.e009574.25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw2672","article-title":"Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma","volume":"12","author":"Wang","year":"2020","journal-title":"Sci Transl Med"},{"key":"2025100303463027000_13.2.e009574.26","doi-asserted-by":"crossref","DOI":"10.1038\/s41698-021-00233-9","article-title":"GD2 CAR T cells against human glioblastoma","volume":"5","author":"Prapa","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"2025100303463027000_13.2.e009574.27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","article-title":"GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas","volume":"603","author":"Majzner","year":"2022","journal-title":"Nature New Biol"},{"key":"2025100303463027000_13.2.e009574.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2019.07.002"},{"key":"2025100303463027000_13.2.e009574.29","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00505-7","article-title":"Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2025100303463027000_13.2.e009574.30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235942","article-title":"CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges","volume":"20","author":"Harrer","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025100303463027000_13.2.e009574.31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe7378","article-title":"SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma","volume":"13","author":"Choe","year":"2021","journal-title":"Sci Transl Med"},{"key":"2025100303463027000_13.2.e009574.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0329-2"},{"key":"2025100303463027000_13.2.e009574.33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41551-022-00896-0","article-title":"Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains","volume":"6","author":"Gordon","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"2025100303463027000_13.2.e009574.34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm1463","article-title":"Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies","volume":"14","author":"Goodman","year":"2022","journal-title":"Sci Transl Med"},{"key":"2025100303463027000_13.2.e009574.35","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq0225"},{"key":"2025100303463027000_13.2.e009574.36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34141-8","article-title":"speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing","volume":"13","author":"Castellanos-Rueda","year":"2022","journal-title":"Nat Commun"},{"key":"2025100303463027000_13.2.e009574.37","doi-asserted-by":"crossref","unstructured":"Castellanos-Rueda R , Wang K-L , Forster JL , et al . Dissecting the role of car signaling architectures on t cell activation and persistence using pooled screening and single-cell sequencing. bioRxiv 2024. doi:10.1101\/2024.02.26.582129","DOI":"10.1101\/2024.02.26.582129"},{"key":"2025100303463027000_13.2.e009574.38","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1016\/j.ymthe.2023.09.008","article-title":"Refining chimeric antigen receptors via barcoded protein domain combination pooled screening","volume":"31","author":"Rios","year":"2023","journal-title":"Mol Ther"},{"key":"2025100303463027000_13.2.e009574.39","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj2820","article-title":"Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL","volume":"8","author":"Bai","year":"2022","journal-title":"Sci Adv"},{"key":"2025100303463027000_13.2.e009574.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"2025100303463027000_13.2.e009574.41","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1603-1"},{"key":"2025100303463027000_13.2.e009574.42","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2021.04.048"},{"key":"2025100303463027000_13.2.e009574.43","doi-asserted-by":"crossref","unstructured":"Lam MS , Aw JJ , Tan D , et al . Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood\u2010Brain Barrier and Glioblastoma. Small 2023;19. doi:10.1002\/smll.202302280","DOI":"10.1002\/smll.202302280"},{"key":"2025100303463027000_13.2.e009574.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02875-1"},{"key":"2025100303463027000_13.2.e009574.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39018-3"},{"key":"2025100303463027000_13.2.e009574.46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/1535-7163.137.3.2","article-title":"Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease","volume":"3","author":"Kawakami","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"2025100303463027000_13.2.e009574.47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2100"},{"key":"2025100303463027000_13.2.e009574.48","doi-asserted-by":"publisher","DOI":"10.1593\/tlo.11175"},{"key":"2025100303463027000_13.2.e009574.49","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-006-9220-3"},{"key":"2025100303463027000_13.2.e009574.50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01392-9","article-title":"Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme","volume":"8","author":"Newman","year":"2017","journal-title":"Nat Commun"},{"key":"2025100303463027000_13.2.e009574.51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1158\/2767-9764.CRC-22-0185","article-title":"Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13R\u03b12-Targeted Chimeric Antigen Receptor T Cells","volume":"3","author":"Starr","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2025100303463027000_13.2.e009574.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.10.002"},{"key":"2025100303463027000_13.2.e009574.53","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.208"},{"key":"2025100303463027000_13.2.e009574.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2006.06.004"},{"key":"2025100303463027000_13.2.e009574.55","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.12.1711"},{"key":"2025100303463027000_13.2.e009574.56","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4478"},{"key":"2025100303463027000_13.2.e009574.57","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99048","article-title":"Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity","volume":"3","author":"Wang","year":"2018","journal-title":"JCI Insight"},{"key":"2025100303463027000_13.2.e009574.58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38703-2"},{"key":"2025100303463027000_13.2.e009574.59","first-page":"945","article-title":"TGF-\u03b2 signaling and its targeting for glioma treatment","volume":"5","author":"Han","year":"2015","journal-title":"Am J Cancer Res"},{"key":"2025100303463027000_13.2.e009574.60","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2007-010"},{"key":"2025100303463027000_13.2.e009574.61","unstructured":"Gordon KS , Perez CR , Garmilla A , et al . Pooled screening for car function in glioblastoma. National Center for Biotechnology Information; 2023. Available: https:\/\/www.ncbi.nlm.nih.gov\/bioproject\/PRJNA957857"},{"key":"2025100303463027000_13.2.e009574.62","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat6753","article-title":"Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function","volume":"11","author":"Salter","year":"2018","journal-title":"Sci Signal"},{"key":"2025100303463027000_13.2.e009574.63","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2559"},{"key":"2025100303463027000_13.2.e009574.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.756"},{"key":"2025100303463027000_13.2.e009574.65","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00256-x","article-title":"The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma","volume":"5","author":"Wei","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2025100303463027000_13.2.e009574.66","unstructured":"Pooled screening for car function in glioblastoma. 2024."},{"key":"2025100303463027000_13.2.e009574.67","article-title":"T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells","volume":"4","author":"Lu","year":"2022","journal-title":"Neurooncol Adv"},{"key":"2025100303463027000_13.2.e009574.68","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12464-3","article-title":"Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease","volume":"10","author":"Szabo","year":"2019","journal-title":"Nat Commun"},{"key":"2025100303463027000_13.2.e009574.69","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-024-01011-x","article-title":"The OrganiX microfluidic system to recreate the complex tumour microenvironment","volume":"24","author":"Adriani","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"2025100303463027000_13.2.e009574.70","article-title":"Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13R\u03b12 are effective against heterogeneous glioblastoma","volume":"5","author":"Schmidts","year":"2023","journal-title":"Neurooncol Adv"},{"key":"2025100303463027000_13.2.e009574.71","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02893-z"},{"key":"2025100303463027000_13.2.e009574.72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2314390"},{"key":"2025100303463027000_13.2.e009574.73","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1661"},{"key":"2025100303463027000_13.2.e009574.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2014.02.012"},{"key":"2025100303463027000_13.2.e009574.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2010.01.003"},{"key":"2025100303463027000_13.2.e009574.76","doi-asserted-by":"publisher","DOI":"10.1038\/nri2014"},{"key":"2025100303463027000_13.2.e009574.77","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.omto.2021.08.014","article-title":"Novel two-chain structure utilizing KIRS2\/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r\/r B-ALL","volume":"23","author":"Sun","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"2025100303463027000_13.2.e009574.78","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3417"},{"key":"2025100303463027000_13.2.e009574.79","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003050","article-title":"Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors","volume":"9","author":"Jan","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2025100303463027000_13.2.e009574.80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymthe.2020.08.016","article-title":"T Cells Expressing NKG2D CAR with a DAP12 Signaling Domain Stimulate Lower Cytokine Production While Effective in Tumor Eradication","volume":"29","author":"Ng","year":"2021","journal-title":"Mol Ther"},{"key":"2025100303463027000_13.2.e009574.81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400330"},{"key":"2025100303463027000_13.2.e009574.82","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000082"},{"key":"2025100303463027000_13.2.e009574.83","first-page":"1043","article-title":"TREM1\/Dap12-based CAR-T cells show potent antitumor activity","volume":"11","author":"Chen","year":"2019","journal-title":"Immunotherapy (Los Angel)"},{"key":"2025100303463027000_13.2.e009574.84","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168245"},{"key":"2025100303463027000_13.2.e009574.85","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031885"},{"key":"2025100303463027000_13.2.e009574.86","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.6.4467"},{"key":"2025100303463027000_13.2.e009574.87","doi-asserted-by":"publisher","DOI":"10.1038\/nri2434"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2024-009574","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T10:46:44Z","timestamp":1759488404000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2024-009574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":87,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,11]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/jitc-2024-009574"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2024-009574","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.04.586240","asserted-by":"object"}]},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}